The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
NFTs, your constant bleating is starting to paint a picture.
You're beginning to sound like someone who sold out early because you thought the company might do a raise but is now regretting it. You seem terrified that a deal might now be struck which would take your desired entry price well away from you and compound the misery of jumping ship too early.
What you really want is for the company to raise funds now, before any deal appears on the horizon, so that the fears you have are alleviated and you can get back in unaffected by the dilution it would cause to everyone who held on.
My diagnosis is a severe case of FOMO. Why else would you would bother to make posts which just labour the same point over and over?
My main takeaway from the presentation is that the only thing that matters now is good BD. Our hopes are pinned on their ability/intention to sell NXP002 for a decent price, which means big pharma.
If they don't do that then it's game over for the rank and file shareholders. Probably not for Gooding & Holland but it definitely will be for us.
" More likely a mid size outfit looking to break into a space"
What would be regarded as mid-size? We want deals with pharma that can pay. Not fairytale promises of heavily capped royalties and mile-pebbles
The self-convincing excuses for delays already seem to be manifesting.
If partners are prepared to wait then why not just wait for us to run out of cash entirely and then the bones out of the carcass?...it won't be too long now!
Goodings job now is to raise the profile as soon as possible, (not with pump and dumpers on TG but with big pharma contacts) and he needs to get a few interested so they are competing. He should have been doing then he was contracted as BD consultant.
We can't afford to wait (we'll, not unless you happen be to able to get yourself some shares in whoever gets this for nothing when the cash runs out)
Can you believe that just over 3 years they were telling us that they were talking to potential partners? If I remember rightly , the numbers being discussed on the boards were that that deal could have been worth around £200m.
Who were they and if they were interested back then, then why are they not interested now? Why is it still a big secret?
It's a big like the big 'insti' investor
I find it hard to feel excited about anything Oxilio
We still don't know the terms of that deal. We don't even know if we'll get a milestone for that, nor how much it will be. Nor do we know how much revenue they'll have to pull in for us to our measly £2.5m capped royalties!
I can understand that the Oxilio shareholders might feel different.
As you say, DG probably feels happy about it...all I can think of is that 'Provention' slide from the Q&A
Thanks for sharing Soup, a I didn't find much of interest in there to be honest.
Also quite alarmed at the use of Provention as an out-licensing example. The parallels are too similar to the Oxilio deal for my liking. In other words, small outfit gets it for peanuts and ends up selling it onto big pharma for billions.. not a happy ending for anyone who's been in since the days before the boardroom clearout.
DG's references to looking towards Oxilio for a 'non-dilutive income' are laughable. What income has there been so far?
Johnny,
My comment yesterday about the punt was mostly a tongue-in-cheek dig based on previous experience of seeing the P&D crews start posting rampy garbage before a few modest transactions occur to 'prove their point' and draw in the gullible.
It has nearly always ended with a fall back to where we were before it started (or worse) and it makes the share look like uninvestable junk, despite the scientific good that is hopefully being achieved in the background.
As for this board being a source of engaging comments, I think we've been lucky with the quality of some of the posters who have contributed in the past and still continue to contribute today. The problem is, we've analysed it to death. Without some new progress on the BD front (or NXP004) and no JH to deliver new products to drive up the interest again, we're just going to end going over old ground.
I think that's one of the main reasons why the comments (including my own) occasionally deteriorate into pointless bickering. The Devil makes work for idle hands...and all that.